---
$id: https://graph.org.ai/products/commodity/51313120
$type: Product
source: UNSPSC
code: "51313120"
title: "Levocetirizine dihydrochloride"
class: "51313100"
classTitle: "Antihistamine or H1 blocker piperazines"
family: "51310000"
familyTitle: "Antihistamines or H1 blockers"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Levocetirizine dihydrochloride

**UNSPSC Code**: 51313120
**Class**: [Antihistamine or H1 blocker piperazines](Antihistamine or H1 blocker piperazines.mdx)
**Family**: [Antihistamines or H1 blockers](../Antihistamines or H1 blockers.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a histamine-1 receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SOD6A38AGA. European Medicines Agency schedules Levocetirizine dihydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20474. Levocetirizine dihydrochloride generally arises in the molecular formula C21H25CLN2O3.2CLH. The term 'levocetirizine dihydrochloride' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule levocetirizine dihydrochloride under HS 29335995 and SITC 51576. As of Q4 2014, LEVOCETIRIZINE DIHYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Levocetirizine dihydrochloride bears US NLM identifiers UMLS ID C1311681 and NCI Concept Code C72814. SMILES: C1CCC(CC1)[C@H](C2CCC(CC2)CL)N3CCN(CC3)CCOCC(=O)O.CL.CL.

